FDA Offers Up Revised PDUFA Date In June For Takeda’s Alogliptin

FDA may be heeding stakeholder calls to set new action dates once an original user fee deadline is missed.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet